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Accumulation of DNA lesions causing transcription stress is associated with natural and
accelerated aging and culminates with profound metabolic alterations. Our understanding of
the mechanisms governing metabolic redesign upon genomic instability, however, is highly
rudimentary. Using Ercc1-defective mice and Xpg knock-out mice, we demonstrate that
combined defects in transcription-coupled DNA repair (TCR) and in nucleotide excision
repair (NER) directly affect bioenergetics due to declined transcription, leading to increased
ATP levels. This in turn inhibits glycolysis allosterically and favors glucose rerouting through
the pentose phosphate shunt, eventually enhancing production of NADPH-reducing
equivalents. In NER/TCR-defective mutants, augmented NADPH is not counterbalanced by
increased production of pro-oxidants and thus pentose phosphate potentiation culminates in
an over-reduced redox state. Skin ﬁbroblasts from the TCR disease Cockayne syndrome
conﬁrm results in animal models. Overall, these ﬁndings unravel a mechanism connecting
DNA damage and transcriptional stress to metabolic redesign and protective antioxidant
defenses.
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Information encoded by DNA is at the hierarchical apex ofvirtually all biological systems and its accurate preservation istherefore essential for life. DNA, however, is constantly
exposed to exogenous and endogenous physicochemical threats
that can modify its nucleotides. Unless promptly resolved, these
alterations corrupt genome ﬁdelity and compromise normal
physiology promoting either cancer or aging and its related dis-
eases1. The cell has therefore developed an intricate network of
mechanisms designated to maintain genome integrity, which
comprises pathways specialized in correcting distinctive classes of
DNA lesions.
Nucleotide Excision Repair (NER) eliminates base pair-
disrupting lesions. It involves more than 30 genes and pro-
gresses along two converging branches; global genome NER (GG-
NER) operates genome-wide, while transcription-coupled repair
(TCR) removes only lesions blocking elongating RNA polymerase
II (RNAPII) to rescue transcription2,3. Defects in GG-NER
therefore lead to the accumulation of base pair-disrupting lesions
in the whole genome, with the notable exception of transcribed
regions, in which DNA damage is removed by still functional
TCR. Correction of the transcribed strand in GG-NER defective
organisms allows cell survival even in the presence of high DNA
damage load. Upon replication, however, accumulated lesions are
bypassed by trans-lesion polymerases, which are more error-
prone and thus increase the onset of mutations and hence cancer.
On the other hand, TCR deﬁciencies cause transcription arrest
because of unrepaired damage, which in turn induces premature
cell death and expression defects accelerating aging. These effects
are particularly pronounced in those organs and tissues that
strongly depend on TCR, for instance post-mitotic tissues, which
cannot dilute accumulating DNA damage by DNA replication
(segmental progeria)1,3. When GG-NER and TCR defects are
combined–as in the case of mutations in the multi-functional
NER protein ERCC1, which also causes deﬁciencies in cross-link
repair–the aging process is further accelerated and extended to
additional organs and tissues. Consistently, in mouse models,
expression of only a truncated Ercc1 allele (Ercc1Δ/−) causes
impaired NER and cross-link repair, increased DNA damage, and
a wide-spread progeroid phenotype that includes prominent liver,
kidney, and neuronal aging4,5. Overall, Ercc1Δ/− mutants exhibit
an exceptionally wide spectrum of natural aging features in a
strongly accelerated fashion, recapitulate the corresponding
human progeroid XFE-1 syndrome, and prove a causative nexus
between DNA damage accumulation and aging-associated multi-
morbidity1,6.
DNA damage accumulation instigates a cellular response
aimed at attenuating growth and activating protective mechan-
isms. Current knowledge of this adaptive, or ‘survival’ response
mainly derives from gene expression experiments in repair-
deﬁcient models4,7 indicating that metabolic redesign is central to
adaptation and suggesting that glucose catabolism is suppressed
in DNA repair deﬁcient mice. Gene expression studies have also
shown parallel up-regulation of genes involved in oxido-reductive
(redox) homeostasis, consistently with a key role of reactive
species (RS) in generating endogenous DNA damage8.
Gene expression, however, remains an insufﬁcient indicator of
enzymes’ levels and activities, and of metabolic ﬂuxes, which are
extensively regulated by allosteric mechanisms9. High con-
centrations of global modulators–e.g. ATP, the main energy
carrier–favor their interaction with target enzymes to induce
structural rearrangements that cause functional (de)activation
and therefore feedback loop control9. Allosteric regulation allows
robust and swift modulation of the metabolic ﬂuxes and therefore
critically contributes to the acute response to stress. On these
premises, the important elements emerged from previous studies
based on gene expression analysis in DNA repair deﬁcient mice
are necessarily incomplete and need to be complemented by
biochemical analyses to resolve the mechanisms coupling meta-
bolic reprogramming to DNA damage accumulation and the
adaptive response.
An eventual role of ATP levels, and therefore of the cellular
energetic status, and of the connected allosteric modulation of
metabolism in response to DNA damage has never been descri-
bed. Yet, the following biochemical concepts suggest that ATP-
mediated regulation might, at least in principle, act on and
respond to DNA damage accumulation to contribute to the
adaptive response: from the energetic standpoint, macro-
molecular synthesis is a highly demanding process10,11 and it is
therefore conceivable that reduced transcription and consequent
translational levels may impact the cellular bioenergetics balance
with direct consequences on metabolism. Hence it is possible that
genomic instability and continued transcription-arrest affect the
cellular bioenergetics balance and metabolism contributing to
activation of the adaptive response.
In this work we describe a molecular process coupling detec-
tion of transcription stalling to metabolic rearrangements oper-
ated by ATP-mediated allosteric mechanisms to potentiate
cellular defenses to stress. Overall, we provide evidence for a
mechanism governing the adaptive response elicited by sustained
block of transcription caused by defective DNA repair.
Results
Defective NER causes progressive decline of transcription. TCR
amends DNA lesions that arrest RNAPII elongation and defective
repair in Ercc1Δ/− mice–which feature severe repair defects that
also include TCR–might predictably compromise transcription. To
test this hypothesis in vivo, we determined global transcription
levels in mice at different ages by measuring incorporation of
intraperitoneally injected 5-ethynyluridine (EU), a uridine analog
detectable with ﬂuorescent azides using a copper (I)-catalyzed
cycloaddition reaction (“click” chemistry)12. EU incorporation,
reﬂecting overall transcriptional output, was signiﬁcantly and
progressively reduced in Ercc1Δ/− livers (Fig. 1a); it transitioned
from ~70% of matched controls at 4 weeks–when polyploidization,
a distinctive hepatic sign of natural aging that is also associated
with of Ercc1 deﬁciency13–15, is already apparent–to ~20% at
16 weeks, to ﬁnally reach a remarkably low level of 10%
at 20 weeks. At this age, many Ercc1Δ/− animals are moribund
and some have already succumbed. Transcription reduction in
Ercc1Δ/− was conﬁrmed in freshly isolated hepatocytes and in
organotypic liver slices from adult mice (age 16 weeks) (Fig. 1b),
ruling out the possibility that the difference in signal was due to
different EU penetration or uptake into livers of control and
experimental groups. Because NER also repairs lesions in the
ribosomal genes16, we measured EU intensities in the nucleolus
versus the rest of the nucleus to examine whether RNA Pol I, RNA
Pol II, or both are involved in this transcriptional collapse. We
found that reduction of EU signal in mutant animals is comparable
in the two sub-compartments (Supplementary Fig. 1), consistently
with a genome-wide operating process. These studies also disclosed
striking heterogeneity in levels of nascent RNA synthesis
among hepatocytes of Ercc1Δ/− mice, in sharp contrast with
the observations in wild-type controls: while in mutant livers
some cells displayed levels of RNA synthesis comparable to wild-
type animals–thus indicating that EU-incorporation per se is
unaffected–other neighboring hepatocytes exhibited very low RNA
synthesis. Moreover, EU incorporation in vivo indicates that in
Ercc1Δ/− heterogeneity changes in time and is more pronounced in
young animals. Such high and time-dependent variability is con-
sistent with a stochastic pattern in the underlying cause, such as
that expected from DNA damage accumulation.
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Transcription decline was independently substantiated by
determining the expression of long and short genes as inferred
from liver transcriptomic data17. Because DNA damage is
stochastic, the likelihood that a gene suffers a lesion is directly
proportional to its length and thus accumulation of DNA damage
is expected to cause preferential depletion in longer
transcripts18,19. Indeed, the expression proﬁle of Ercc1Δ/− livers
(16-weeks old) was relatively enriched in transcripts from short
genes and signiﬁcantly depleted in transcripts of long genes
(Fig. 1c, Supplementary Table 1).
We investigated whether strong overall transcription decline
was attributable to reduced RNA polymerase II (RPB1) and
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Fig. 1 Defective NER causes transcription block. a Incorporation of the uridine analog EU into nascent RNA in vivo is reduced in Ercc1Δ/− mouse livers and
further decreases with age. EU was injected in the peritoneum of 4, 16, and 20-week old animals; tissues were harvested 5 h after injection. EU
incorporation occurs predominantly in hepatocytes compared to transcriptionally less active epithelial cells (arrowheads); Sytox green nucleic acid staining
is detectable in both cell types. Polyploid nuclei (asterisk), which are a hallmark of natural liver aging, are already detectable in 16 and 20-week old Ercc1Δ/−
mutants; n≥ 80 cells from 3 mice per group. b Decreased EU incorporation (3 mM, 2 h) in freshly isolated primary hepatocytes from adult mice (16-week
old, n= 3). Scatter dot plot represents the EU intensity distribution of biological replicates. c Graphical representation of the correlation between
expression levels (DEG - differentially expressed gene; FC- fold-change) and gene length in 16-week old Ercc1Δ/− versus wild-type livers. In Ercc1Δ/−, 356
genes were up-regulated and 382 down-regulated; the median length of up-regulated genes is 17371 bp; (red arrowhead), while that of down-regulated
ones is 65010 bp (green arrowhead). Mann–Whitney test (p < 0.0001) indicates that gene length distribution between up- and down-regulated genes is
statistically signiﬁcant. Transcription decline in Ercc1Δ/− is more pronounced in longer genes. Each point represents an individual gene. Gene length is in
log10 scale, while gene expression level is in log2. d Representative western blot of RNA pol II (RPB1) expression and phosphorylation levels of Ser2
(elongating RNA pol II) and Ser5 (initiating RNA pol II) residues in 4, 16 and 20 week-old mice (n≥ 3 per group, top panel). Bar graphs from 2 independent
technical replicates (lower panel). e Ubiquitinated RNA pol II is undetectable in both Ercc1Δ/− and control livers. Liver lysates were incubated with Ubiquitin
Afﬁnity Matrix (TUBE2); both unbound (input) and eluted (bound) fractions were resolved by SDS/PAGE and probed with antibodies against Ser2- and
Ser5-phosphorylated RNA Pol II and Ubiquitin. Error bars indicate mean ± s.e.m. *p < 0.05; ***p < 0.001; Student’s t-test. Scale bar: 50 μm. Original data and
images are provided as a Source Data ﬁle
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therefore evaluated its expression at mRNA and protein level, as
well as its phosphorylation status in Ercc1Δ/− mice of different
ages. Immunoblot analysis did not reveal a drop in RNA pol II
largest subunit, RPB1 (Fig.1d–RPB1 tot). Analysis of mRNA
levels also failed to indicate a down-regulation of RNA pol II
subunits (Supplementary Table 2). To gather further insights on
transcription, we investigated RNA pol II phosphorylation on
Ser2 and Ser5 in its C-terminal repeat domain, which respectively
reﬂect transcription elongation and initiation20. Immunoblot
analysis did not detect a decline in time in Ser2 or Ser5
phosphorylation in Ercc1 liver extracts; in fact, there is a even
moderate increase in Ser5 phosphorylation (see Fig. 1d). We also
explored whether transcription decline in Ercc1Δ/− is associated
with increased ubiquitination of RNA Pol II, which–despite
involvement of non-conventional signaling functions of ubiqui-
tinylaiton in genome integrity maintenance21–has been shown to
target the enzyme to degradation as a consequence of DNA
damage22,23. Immunoblot analysis following immunocapture of
ubiquitinated proteins, however, failed to reveal any signal for
RNA Pol II (Fig. 1e), in agreement with our observation that total
RNA pol II levels in Ercc1Δ/− livers were unaffected. General
ubiquitination increased only in 20-week old Ercc1Δ/− mice
(Supplementary Fig. 2). Collectively these data clearly rule out a
decrease of RNA Pol II in Ercc1Δ/− mice that can explain the
dramatic decline in transcriptional output. The ﬁnding that the
level of elongating, Ser2-phosphorylated RNA Pol II at 16 and
20 weeks is unaffected while transcriptional output is collapsing
(Fig. 1a) suggests that these elongating RNA Pol II molecules are
non-productive, in line with the concept that they may be stalled
because of accumulating, unrepaired DNA lesions.
Decreased transcription leads to elevated ATP pool. Tran-
scription is a high energy-demanding process and reduced tran-
scription likely also diminishes translation, which is even more
energy-consuming. Hence reduced transcription may impact the
overall cellular energy status. We initially probed energy para-
meters by monitoring the activity of the major cellular ATP
generator, mitochondria, in cells where transcription was chemi-
cally blocked and found that 6 h treatment with 5,6-dichloro-1-
beta-D-ribofuranosylbenzimidazole (DRB) suppresses mitochon-
drial oxygen consumption in both transformed hepatocytes
(Fig. 2a) and primary ﬁbroblast cultures (Supplementary Fig. 3A).
This is a general effect, genuinely attributable to transcription
block, because it could be reproduced by other inhibitors acting
through different mechanisms: alpha-amanitin and actinomycin D
(Supplementary Fig. 3A). A more direct link between transcription
stalling and bioenergetics emerges from the analysis of ATP levels,
which–as expected–are increased in cells exposed to transcription
inhibitors (Fig. 2b, Supplementary Fig. 3B).
In line with these observations in vitro, severely reduced
transcription in Ercc1Δ/− livers (16-week old, Fig. 1a) is paralleled
by higher intracellular concentration of ATP and ATP/ADP ratio
(Fig. 2c, d); as expected, phosphorylation of AMPK, which
responds to ATP deﬁcit rather than its surplus, is unchanged in
NER mutants (Supplementary Fig. 4A, B). The ATP surplus in
Ercc1Δ/− mice, however, is not caused by potentiation of the
major biochemical pathways producing ATP: mitochondrial
respiration and glycolysis. Analysis of freshly isolated primary
hepatocytes, in fact, revealed that mitochondrial basal respiration
was comparable in Ercc1Δ/− and controls. In addition, measures
of oxygen consumption rates show that mitochondria from
Ercc1Δ/− specimens present features such as diminished reserve
capacity (i.e. induced by the uncoupler FCCP) and rotenone-
sensitive respiration–which is principally attributable to complex
I–that rather point to bioenergetics deﬁcits (Fig. 2e, f).
Additionally, in Ercc1Δ/− liver glycolysis is reduced in both basal
conditions and under stimulation with glucose (Fig. 2g). Con-
sistently, Ercc1Δ/− mice display reduced mRNA levels of pyruvate
dehydrogenase beta subunit (Pdhb), which converts the end-
product of glycolysis pyruvate into acetyl-CoenzymeA (acetyl-
CoA) for the Krebs’ cycle. Further suppression at the level of
Kreb’s cycle entry point is indicated by reduced mRNA levels of
cytoplasmic Acetyl-Coenzyme A Synthetase (Acss2), which is also
involved in the production of acetyl-CoenzymeA, and of ATP-
citrate synthase (Acly), which catalyzes the condensation of
oxaloacetate and Acetyl-CoenzymeA to generate citrate (Supple-
mentary Tables 3,4). Collectively, these data strengthen the
concept that increased ATP levels are the consequence of
decreased consumption rather than enhanced production.
Analysis of glycolytic function, however, also reveals that
maximal capacity after administration of ATP synthase inhibitor
oligomycin–which completely redirects ATP production on
glucose metabolism–is retained in Ercc1Δ/− liver (Fig. 2g). This
evidence suggests that the molecular machinery for glucose
catabolism is present in Ercc1Δ/− mutants but, unless stimulated
by drastic conditions (i.e. oligomycin administration), its function
is suppressed. Importantly, the rapid completion of the glycolysis
assay ( <1 h) excludes that these differences are caused by altered
transcription. In fact, steady state mRNA levels of key glycolytic
enzymes are unchanged in Ercc1Δ/−mice (Fig. 2h, Supplementary
Table 4). Collectively, these elements suggest allosteric modula-
tion as alternative regulatory mechanism.
ATP alterations cause redesign of carbohydrate ﬂuxes. Besides
its cardinal role in bioenergetics, ATP functions as a potent
allosteric regulator. For instance, in circumstances of energetic
surplus, high ATP levels inhibit the master regulator of glycolysis,
phosphofructokinase (PFK), via a negative feedback loop pre-
venting superﬂuous glucose catabolism24–26. We therefore
speculated that abnormally elevated ATP levels–as those induced
by transcription stalling–might elicit similar metabolic rearran-
gements. First, we tested the effects of chemical inhibition of
transcription on PFK activity in cell cultures and found that, in
DRB-treated samples, increased ATP levels (shown in Fig. 2a) are
paralleled by signiﬁcantly decreased PFK activity (Fig. 3b), con-
sistently with reduced basal glycolysis in Ercc1Δ/− livers (descri-
bed in Fig. 2g). Decreased PFK activity, and thus inhibition of
glycolysis, may in turn favor glucose catabolism through the
alternative pentose phosphate pathway (PPP), which branches
from the glycolytic pathway itself (Fig. 3a, Supplementary
Table 5). To investigate whether allosteric inhibition of PFK
activates the PPP switch, human primary ﬁbroblasts were treated
with the PFK allosteric modulator citrate27, which is internalized
via speciﬁc membrane transporters expressed in this cell type
(Supplementary Fig. 5A). Citrate treatment caused reduction of
both PFK activity and downstream glycolysis (Fig. 3b, d) paral-
leled by increased activity of glucose-6-phosphate dehydrogenase
(G6PD) (Fig. 3c) i.e. the entry-step for glucose in the PPP. These
elements support the notion that PFK inhibition favors glucose
re-routing to the PPP through the G6PD node.
Hence, we evaluated the possibility that elevated ATP levels in
livers of 16-week old Ercc1Δ/− mice might be also associated with
glucose re-routing through the PPP. Indeed, Ercc1Δ/− liver
extracts exhibit both reduced PFK and increased G6PD activity
(Fig. 3e), which is in turn associated with signiﬁcantly augmented
levels of PPP metabolic intermediates (Fig. 3f). Metabolites
tracing with [1–213C2] glucose further conﬁrmed potentiation of
the PPP in Ercc1Δ/− (Fig. 3g). Observations in Ercc1Δ/− in vivo
therefore recapitulate the paradigm of citrate-induced glucose
rerouting in cell cultures. Importantly, transcriptomic analysis
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failed to detect any differentially regulated genes in the PPP,
therefore supporting that glucose rerouting occurs through an
allosteric mechanism (Supplementary Table 5).
Metabolic redesign culminates reductive redox stress. Glucose
rerouting from glycolysis to the PPP constitutes a rapid metabolic
strategy to counteract oxidant stress. This pathway provides
reducing equivalents in the form of NADPH, the upstream
driving force to maintain redox homeostasis via the glutathione
(GSH) and thioredoxins (Trxs) based thiol-disulﬁde circuits
(Fig. 4a)28. Accordingly, our previous ﬁndings in hepatocytes and
ﬁbroblasts–showing that persistent chemical inhibition of tran-
scription (4 h) leads to increased intracellular levels of ATP,
diminished PFK activity, and decreased glycolysis (Figs. 2a, 3b,
Supplementary Fig. 3)–are paralleled by concomitant reduced
redox state (Fig. 4b). These were general effects, genuinely attri-
butable to decreased transcription, because three inhibitors acting
through different mechanisms–alpha-amanitin, Actinomycin D,
and DRB–elicited the same effects on glycolysis and redox
homeostasis.
In vivo, in livers of 16-week old Ercc1Δ/− mice, the increased
ﬂux of carbohydrate through the PPP mice is paralleled by a
signiﬁcant reduction of the NADP+/NADPH redox couple
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(Fig. 4c), which culminates, as expected, in the abnormal
reduction of the GSSG/GSH redox couple (Fig. 4d) and of the
global thiol-disulﬁde equilibrium (Fig. 4e), which was determined
by the ratiometric measurement of oxidized and reduced
cysteines speciﬁcally derivatized with maleimide-conjugated
ﬂuorophores29,30.
These metabolic rearrangements are also accompanied by a
robust increase in the biosynthesis of molecules controlling redox
homeostasis via thiol-disulﬁde mechanisms. In particular, NER/
TCR-defective mice show selective increased transcription of
glutamate-L-cysteine ligase (Glcl) (Fig. 4f), a key enzyme in the
synthesis of glutathione, and increased GSH and Trx-1 protein
levels (Fig. 4g, h). Intriguingly, at 16 weeks of age, the strong
antioxidant response is not associated with increased production
of reactive species (RS), as indicated by reduced signal in freshly
dissociated Ercc1Δ/− hepatocytes loaded with the generic RS
sensor CM-H2DCFDA or with the mitochondrial superoxide
probe mitoSOX (Fig. 4i). Consistently, protein carbonyls–which
are a footprint of RS31 because protein repair capacity is very
limited and largely conﬁned to the reduction of oxidized sulfur-
contain amino acids- are lower in 16-week old Ercc1Δ/− livers
compared to wild-type controls (Supplementary Fig. 6). Overall,
potentiation of the PPP and increased reduction of the NADP
+/NADPH redox couple without parallel increase in ROS cause a
counterintuitive reduced redox state in Ercc1Δ/− liver.
To further probe the reductive redox balance in Ercc1Δ/−
mutants, we performed toxicity assays in vitro and in vivo to
assess sensitivity to chemicals targeting the intracellular redox
state. Murine Ercc1-deﬁcient ﬁbroblasts display increased resis-
tance to the pro-oxidant diamide (Fig. 4j), which speciﬁcally
promotes formation of disulﬁdes32. Consistently, chronic treat-
ment of Ercc1Δ/− mice to the pro-oxidant toxin rotenone
dissolved in drinking water did not shorten lifespan.
On the other hand, chronic exposure to the reducing agent N-
acetylcysteine (NAC)–which has been extensively used as a
therapeutic antioxidant also in humans–signiﬁcantly shortened
lifespan in Ercc1Δ/− mice (Fig. 4k), pointing to abnormally
reduced environment in this mutant strain.
Manipulation of ATP levels elicit metabolic redesign. Collec-
tively, our ﬁndings identify a mechanism coupling defects in NER
and TCR, and transcription decline to abnormal redox reduction
stress via ATP surplus and metabolic redesign. Additionally,
chemical inhibition of transcription in vitro recapitulates the
ﬁndings in TCR-defective mouse mutants.
To further explore this model, we manipulated the crucial
driving factor in the process, i.e., intracellular ATP concentration
in mouse primary ﬁbroblasts, by administration of nucleosides,
i.e., adenosine or a mix of the four nucleosides adenosine, uridine,
cytidine, and guanosine (AUCG. Fig. 5a). After uptake, nucleo-
sides promote synthesis of nucleic acid precursors via the salvage
pathway33,34, which is energetically favored over expensive de
novo synthesis. ATP expenditure is therefore reduced with
consequent increase of ATP intracellular levels35,36. We used PFK
and G6PD activity, as well as redox balance as metabolic readout
measures.
Two days treatment of primary ﬁbroblasts with adenosine, or
with the combination of the four nucleosides, elevated ATP/ADP
ratios (Fig. 5a) and reduced PFK activity (Fig. 5b), even though
we failed to detect signiﬁcant differences in G6PD in these
conditions (not shown). These effects were more pronounced in
the treatment with adenosine alone, which was therefore used in
subsequent experiments. As expected, adenosine treatment
inhibited glycolysis (Fig. 5c) and shifted thiol-disulﬁde equilibria
towards a reduced state (Fig. 5d). Metabolic reprogramming was
not due to down-regulation of glycolytic enzymes at transcrip-
tional level or by decreased bioavailability of glucose, as evidenced
by unaltered expression levels of key glucose transporters
(Fig. 5e).
Alterations in glucose metabolism, including impaired glyco-
lysis, characterize a subgroup of metabolic inborn errors that
often manifest at very early life stages37. We therefore questioned
whether the defects associated with Ercc1 mutation manifest in
very young individuals. We measured transcription levels, ATP
concentration, PFK and G6PD activity, NADP+/NADPH ratio,
and thiol/disulﬁde redox state also in young Ercc1Δ/− mice. Four-
week old animals failed to exhibit alterations in these hallmarks
(Supplementary Fig. 7A-F, H) despite an increase in transcription
of redox genes (Supplementary Fig. 7G) and the decrease in
transcription output reported in this study (Fig. 1a). Reduction of
transcription at 4 weeks, however, was less pronounced than at
later time points (Fig. 1a). These data indicate that detected
metabolic changes are progressive in time and appear later in life,
during aging, lending support to the possibility that the
phenomena observed in Ercc1Δ/− mice are caused by time-
dependent accumulation of cellular alterations, possibly DNA
damage.
Altogether, these elements suggest that a persistent diminish-
ment in transcription output redesigns glucose metabolism and
augments the reductive capacity of the cell, and propose a further
connection between defective DNA repair, metabolism,
and aging.
Glucose rerouting and reductive stress in the Xpg−/− NER
model. We next asked if ATP-mediated rerouting of glucose
Fig. 2 Diminished transcription leads to increased intracellular ATP levels. a Mitochondrial respiration–measured in real time as oxygen consumption rate
(OCR)–is reduced in hepatocytes after the injection of the chemical transcription inhibitor DRB, thus indicating the bioenergetics burden of macromolecular
synthesis (left trace). After 6 h of DRB treatment, transcription is reduced to 66.4% of its original level (right panel). b 6-h incubation with DRB leads to
increased intracellular ATP levels, which conﬁrm the bioenergetics burden of transcription; n≥ 4, data were collected from 2 independent technical
experiments. c, d HPLC analysis indicates that defective NER in Ercc1Δ/− (16 weeks) is associated with increased ATP levels and ATP/ADP ratio in vivo (16
week-old animals); n≥ 4, data were obtained from 2 independent technical experiments. e, f Measure of respiration in primary hepatocytes shows that
increased ATP levels in Ercc1Δ/− are not the consequence of augmented mitochondrial respiration. OCR was measured in freshly extracted hepatocytes in
basal conditions and after sequential injections of the following molecules modulating mitochondrial activity: oligomycin, FCCP, rotenone and antimycin-A
(see methods for details). Basal mitochondrial respiration and proton leakage are unaltered, while ATP-dedicated respiration, maximum respiratory
capacity and rotenone-sensitive respiration are decreased in mutants. Cells were extracted from n≥ 3 mice per group, data were collected from 2
independent technical replicates. g Increased ATP levels in Ercc1Δ/− are associated with glycolysis inhibition. Basal- and glucose-stimulated glycolysis,
measured as extracellular acidiﬁcation rate (ECAR), is decreased in Ercc1Δ/− mutants; oligomycin-stimulated glycolytic capacity, however, is retained and
comparable to WT. Left, Seahorse Extracellular Flux Analyzer trace; right, bar graph of basal and glucose- and oligomycin-stimulated ECAR. Cells were
extracted from n= 3 16-week old mice, 3 technical replicates. h Quantitative PCR indicates that the observed effects do not depend on expression changes
in rate-limiting glycolytic enzymes or in glucose transporters (n≥ 4 mice per group, 16 weeks). Error bars indicate mean ± s.e.m. *p < 0.05, **p < 0.01,
***p < 0.001; Student t-test. Original data are provided as a Source Data ﬁle
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through the PPP to produce excess reducing equivalents in the
form of NADPH were general consequences of defective TCR
augmented by a GG-NER defect rather than other repair defects
associated with Ercc1 deﬁciency. We therefore extended analysis
to another repair mutant with a combined GG-NER/TCR defect,
the Xpg knock-out mouse (Xpg−/−)38. Here, we evaluated the
hallmarks of metabolic redesign previously observed in Ercc1Δ/−
mice: transcription decline, increased ATP, PFK inhibition, G6PD
activity, and reduced thiol/disulﬁde redox state. 14-weeks-old
Xpg−/− mice indeed display all of these features (Fig. 6a–g),
recapitulate previous observations in Ercc1Δ/−, and therefore
demonstrate the general nature of our ﬁndings.
Metabolic reprogramming in the TCR disease Cockayne syn-
drome. To determine the relevance of our ﬁndings for human
diseases, we investigated segmental progeroid syndromes caused
by GG-NER/TCR defects, speciﬁcally in primary ﬁbroblasts39,39
from a patient (96RD235) suffering profound GG-NER/TCR
defects due to a very severe mutation caused by a deoxycytidine
deletion in the codon coding for the Arg45 in the NER gene XPG,
that causes a C-terminal truncation in the protein39–41. The
severe clinical outcome combines xeroderma pigmentosum and
Cockayne syndrome (XP/CS) symptoms, similar to the Xpg−/−
mouse model used above42.
Previous studies have already demonstrated increased ATP
levels in CS primary ﬁbroblasts;43 here, we show that XP/CS
primary ﬁbroblasts also exhibit reduced PFK activity (Fig. 7a)
paralleled by decreased glycolysis (Fig. 7b, c) and alterations in
the thiol-disulﬁde redox equilibria toward a reducing state
(Fig. 7d). G6PD activity showed a consistent trend, which
however did not reach statistical signiﬁcance (Fig. 7e). These
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ﬁndings conﬁrm the principal observations in the mouse repair
mutants and extend them to the corresponding human disorder.
Discussion
In this study we demonstrate a progressive dramatic decrement of
transcription in NER/TCR-defective mouse models. Although,
ERCC1 and other NER/TCR factors have also been associated
with transcription regulation44, we favor the idea that–rather than
being caused by anomalies in or lack of speciﬁc transcription
factors–the collapse of RNA synthesis observed in the liver of
Ercc1 and Xpg mutant mice is the consequence of compromised
repair function (and consequently DNA damage). This possibility
is supported by multiple arguments: ﬁrst, the drastic and pro-
gressive decline of overall transcriptional output (up to 90%)
(Fig. 1a) is difﬁcult to reconcile with anomalies in or lack of a
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speciﬁc transcription factor. These molecules, in fact, control
expression of a speciﬁc subset of genes and defects in a speciﬁc
factor would affect expression of its target genes, with immediate
rather than progressive consequences, the latter occurring over a
timespan of months. Second, here and in a previous study17 we
reported that transcription decline is gene length-dependent
(Fig. 1c); hitherto, no transcription factor has been described that
regulates genes based on gene size, at least to our best knowledge.
Third, the gene length effect is accurately recapitulated in a dose-
dependent fashion when cultured cells are exposed to
transcription-blocking UV damage, and is exaggerated and per-
manent in TCR mutants45. Fourth, our observation that unaltered
levels of elongating Ser2-phosphorylated RNA Pol II in aged
Ercc1 liver (Fig. 1d) are paralleled by drastic reduction in total
transcription output, which in Ercc1 mutants is only 10% of
controls, implies that many RNA Pol II molecules in elongation
mode are not productive; this evidence is consistent with DNA
damage mediated RNA Pol II stalling. Altogether, these argu-
ments strongly favor time-dependent accumulation of DNA
damage as the principal cause of the transcription stress.
Unfortunately, hitherto no reliable methods exist to accurately
measure physiological levels of spontaneous DNA lesions, with
the exception of cyclopurines, which have been reported to be
elevated in liver of Ercc1 mouse mutants46. Since the latter oxi-
dative NER lesions are capable of transcription stalling47,48, they
are candidates for at least part of the transcription problems
described in this work.
Our study proves that transcription arrest in defective DNA
repair organisms leads to ATP surplus, which in turn inhibits the
key glycolytic enzyme PFK to promote glucose rerouting through
the PPP and ultimately favors production of reducing equivalents
in the form of NADPH (Fig. 7f). Thus, we provide evidence for an
adaptive mechanism that couples defects in TCR and consequent
transcription stalling with redesign of glucose metabolism and
activation of antioxidant defenses. The process can be framed as
part of the ‘survival response’ that we described at transcriptional
level previously;4,49,50 in this study, we extend these ﬁndings
demonstrating that metabolic reprogramming depends on ATP-
dependent allosteric mechanisms and we therefore reveal a faster
cellular response to DNA damage. In fact, unchanged levels of
glycolytic enzymes mRNA and the rapid time-course of cell
culture experiments (i.e., insufﬁcient to observe transcription
effects) indicate that the process is independent of and precedes
the well-documented transcriptional response. Elevated ATP
levels in NER-deﬁcient primary human cell have been previously
described in other independent studies43. The consequences of
altered levels of this potent allosteric modulator on metabolism
and its link with transcriptional stress, DNA damage, and the
antioxidant response, however, have to our best knowledge never
been described. Obviously, additional ATP based mechanisms
independent from allosteric modulation may participate in the
adaptive cellular response, possibly by reshaping the transcrip-
tional landscape. In bacteria, for instance, it has been demon-
strated that both high and low intracellular ATP concentrations
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affect macromolecular synthesis11,51 and that some promoters are
directly activated by ATP11,52. These mechanisms, however, have
not been investigated in comparable detail in eukaryotic
systems–at least to our best knowledge–and further studies will be
necessary to elucidate how intracellular ATP concentration reg-
ulates the transcriptome.
Of note, we provide evidence that chemical inhibition of RNA
pol II recapitulates the features observed in NER mutants; how-
ever, additional studies will have to address also the contribution
of both RNA pol I to the observed metabolic changes, given that
TC-repair can amend lesions in ribosomal DNA16.
Increasing evidence highlights the relevance of metabolism
modulation and of the response to DNA damage in the complex
process of aging;53,54 however, whether and possibly how they are
related has remained largely elusive. Metabolic reprogramming to
favor the PPP over glycolysis in DNA repair deﬁcient systems
may be framed as part of the survival response previously
described in segmental progeria4,7,50. Glucose metabolism, in fact,
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Fig. 7 Primary ﬁbroblasts derived from skin biopsy from a patient suffering profound GG-NER/TCR defects due to a gene XPG mutation show metabolic
modiﬁcations. a PFK activity is reduced in the patient’s cell and b, c is paralleled by decreased glycolysis, measured as ECAR in extracellular ﬂux analysis.
Line graph in B represents real time glycolysis changes in basal condition and upon stimulation with glucose and oligomycin. n≥ 3, data were obtained from
two independent experiments. d In the patient’s cells, the thiol-disulﬁde redox equilibrium, which was measured after derivatization of oxidized and
reduced cysteines with maleimides conjugated with different ﬂuorophores, is shifted toward a reducing state. n≥ 150, data were obtained from three
independent experiments. e G6PD activity shows a consistent trend, which however did not reach statistical signiﬁcance. n= 3, data were obtained from
two independent experiments. f Schematic representing the model we propose. Accumulation of transcription-blocking lesions triggers an acute
antioxidant response driven by metabolic redesign. In normal conditions, pro-oxidant species are the principal source of DNA damage. However, in GG-
NER/TCR-deﬁcient mice DNA damage accumulation is not caused by increased oxidative stress, but is rather due to compromised repair. Thus, the
intrinsic antioxidant response in this case is not paralleled by increased reactive species and it culminates in an overall reduced redox state. Error bars
indicate mean ± s.e.m. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t-test. Original data are provided as Source Data ﬁle
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plays a major role in the aging process and has a profound
inﬂuence on lifespan, as indicated by the relevance of IGF-1/
insulin signaling for longevity. Moreover, reduction of glucose
metabolism–and of glycolysis in particular–have been even pro-
posed as mimetics of dietary restriction, the most efﬁcient form of
intervention to delay aging55, even most prominently in DNA
repair deﬁcient accelerated aging mutants17.
One apparent consequence of rerouting metabolism from
glycolysis through the PPP is to mount a ﬁrst-line defense against
oxidation, which is critical to counteract stress56 including
genomic stress caused by oxidative DNA damage. The nexus
between activation of the PPP shunt and DNA damage is not
unprecedented. For instance, glucose-6-phosphate dehydrogenase
(G6PD), which catalyzes the ﬁrst reaction in the PPP, protects
against endogenous DNA damage57. Increased activation of
G6PD can be mediated by the DNA damage response protein
ATM, which is a primary sensor for double-strand breaks, to
stimulate the PPP pathway, synthesis of nucleotides, and anti-
oxidant response58. In this case, however, PPP activation pro-
ceeds through Hsp27-mediated G6PD stabilization.
An additional link between the PPP and ATM stems from
observations in rheumatoid arthritis patients, who display
deranged DNA repair in T-cells59,60. Here, an excessively reduced
redox environment prevents ATM activation, which in turn
allows T-cells bypassing the G2/M checkpoint. The latter results
in augmented proliferation and consequent enrichment of the
pro-inﬂammatory pool population61. Accordingly, administra-
tion of pro-oxidants in rheumatoid arthritis counterbalances the
abnormally reductive redox environment, restores redox signal-
ing, and suppresses synovial inﬂammation62.
These independent results from our and other laboratories
consistently point to a key role of the PPP in the response to
DNA damage, demonstrating that multiple pathways converge on
its potentiation to compensate for genomic stress. Unlike pre-
vious evidence, however, our study reveals a mechanism based on
allosteric regulation, a biochemical strategy allowing highly rapid
adaptation of cellular function against stress.
Augmented redox-buffering capacity is intrinsic to longevity
and is a prerogative of long-lived species63. The increased avail-
ability of redox-sensitive thiol groups, which we found in GG-
NER/TCR-deﬁcient mice, is fundamental to counterbalance oxi-
dative stress. In this work we have shown that short-lived, pro-
geroid NER-deﬁcient mice display an abnormally reduced redox
state; albeit surprising and counterintuitive given the notion that
oxidation increases with age64 and that longevity -instead of a
short lifespan- is associated with enhanced redox-buffering.
However, our ﬁndings are in line with previous reports showing
higher sensitivity of ﬁbroblasts from patients with severe DNA
repair defects to the thiol-reducing agent dithiothreitol (DTT)65;
while this feature could be caused by effects not directly related to
reducing stress–for instance DTT mediated ER stress and con-
sequent failure to properly fold proteins–it certainly establishes a
nexus between reductive redox stress and defective DNA repair.
To explain this apparent paradox, we propose the model depicted
in Fig. 7f. Our data demonstrate that accumulation of
transcription-blocking lesions triggers an acute antioxidant
response driven by metabolic redesign and indicate that evolution
selected mechanisms where DNA damage sensing and anti-
oxidant capacity potentiation are intrinsically coupled. This
concept is consistent with the dominant idea that, in normal
conditions, pro-oxidant species are a principal source of DNA
damage. In GG-NER/TCR-deﬁcient mice, however, DNA damage
accumulation is not caused by increased oxidative stress, but is
rather due to compromised repair. Thus, the intrinsic antioxidant
response in this case is not paralleled by increased reactive species
and it culminates in an overall reduced redox state, as we have
shown in repair-deﬁcient liver samples (Fig. 4e). Of note,
abnormal reductive environment–which is deleterious and has
been associated with hyperactivation of the PPP in some forms of
cardiomyopathies and in the autoimmune syndrome rheumatoid
arthritis62,66–might also be implicated in the pathogenesis of
diseases caused by GG-NER/TCR defects (i.e. CS and XP) and its
role in the progression of these disorders should be explored
further. Furthermore, future investigations should determine
whether chemotherapeutic agents acting through mechanisms
involving transcription block–for instance platinum-based anti-
neoplastics–involuntarily potentiate the PPP and antioxidant
defenses in cancer cells, therefore diminishing the efﬁcacy of the
treatment. Finally, our ﬁndings suggest that trials with anti-
oxidants might not be recommended for DNA repair deﬁcient
progeroid patients and further research is certainly required to
determine the validity of such strategies in these diseases.
Multiple lines of evidence support a causative role for DNA
damage accumulation and TCR defects in natural aging1 and
associated morbidities, for instance Parkinson’s and Alzheimer’
disease67–69. Moreover, we found perturbation in transcription to
be intrinsic to the aging process from both a qualitative and
quantitative standpoint: transcriptional output decreases in nat-
ural aging17,70,71 and studies at single cell level demonstrated an
age-related increase in variance and background noise in gene
expression72. Our ﬁndings therefore strengthen the parallels
between accelerated and natural aging, conﬁrm the validity of the
repair mutants, and highlight declining transcription as a novel
important parameter in the aging process. Future studies are
warranted to determine in greater detail the contribution of
transcription decline to natural aging and physiological dete-
rioration. In conclusion, our study provides mechanistic insights
about the metabolic consequences of DNA damage accumulation
and paves the road for future investigations in multiple ﬁelds of
biomedical sciences.
Methods
Reagents. All reagents were purchased by Sigma-Aldrich unless otherwise
speciﬁed.
Animals. The generation and characterization of TC-NER deﬁcient Ercc1Δ/− and
Xpg−/− mice has been previously described15,38. Mice were generated in an FVB:
C57BL/6 J (50:50) genetic background and wild type littermates were used as
controls. Animals were kept on a regular diet and housed at the Animal Resource
Center (Erasmus University Medical Center), which operates in compliance with
the “Animal Welfare Act” of the Dutch government, following the “Guide for the
Care and Use of Laboratory Animals” as its standard. This study was approved by
the Erasmus University Medical Center ethical committee for animal welfare.
Mutant mice and respective controls (males and females) were used at the age of 4,
16, and 20 weeks old for Ercc1Δ/− and 14 weeks old for Xpg−/−.
Primary hepatocytes isolation. Primary hepatocytes were isolated from 4 to 16
and 20 weeks old animals by the collagenase perfusion method73, with modiﬁca-
tions. Brieﬂy, liver was perfused via cannulation of the abdominal vena cava
inferior using wash buffer (HBSS modiﬁed with 10 mM HEPES and 16 mM
NaHCO3) at 37 °C at a ﬂow rate of 7 ml/min. After 10 min, the buffer was switched
to the perfusion solution (HBSS, 10 mM HEPES, 16 mM NaHCO3, 150 U/mL
collagenase type IV (Sigma) and 5 mM CaCl2) and the liver was perfused for 14
min. The liver was then excised, minced and dissociated tissue was ﬁltered using a
70 µm sterile ﬁlter in washing medium (DMEM containing 10% FBS, 1% Pen/
Strep, 0.5 U/mL insulin, 20 ng/mL murine EGF, 7 ng/ml glucagon and 7.5 µg
hydrocortisone). Parenchymal cells were puriﬁed by centrifugation (50 g, at 4 °C
for 10 min) using Percoll (GE Healthcare) in 1:1 dilution with wash medium.
Viability, which was typically around 90%, was determined using Trypan Blue
exclusion. Isolated liver cells were then seeded on previously Cell-Tak (22.4 μg/ml;
354240, BD Biosciences) coated plates or coverslips, and maintained in DMEM
containing 10% FBS, 1% Pen/Strep.
Nascent RNA synthesis detection in primary cells and tissues. Quantiﬁcation
of nascent RNA synthesis was performed with Ethylene uridine (EU) taking
advantage of the copper (I)-catalyzed cycloaddition reaction between azides and
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terminal alkynes, as described in a previous study12. The experiments were per-
formed using the Click-iT Nascent RNA capture kit (C10365, Invitrogen).
To detect de novo transcription in primary hepatocytes, 3 mM EU was
dissolved into the culture medium for 2 h. Cells were then washed twice with PBS,
and then blocked with 3% BSA in PBS for 30 min. The reaction was then
performed according to the manufacturer’s instructions.
To measure de novo transcription in mouse tissues, animals received an
intraperitoneal injection (i.p.) of EU (0.088 mg/g in sterile PBS). Tissues were
harvested 5 h after injection and were ﬁxed in paraformaldehyde overnight, kept in
30% sucrose for additional 24 h, embedded in Tissue-Tek CRYO-OCT (1437365,
Fisher Scientiﬁc) and cryostat-cut in 10 μm sections. For the staining, the sections
were rinsed with PBS, incubated 30 min in a PBS solution containing 3% BSA and
then treated at room temperature with a solution containing 100 mM Tris, pH 8.5,
1 mM CuSO4, 25 µM tetramethylrhodamine-5-carbonyl azide and 100 mM
ascorbic acid for 30 min. The sections were then washed twice with PBS-BSA, 2
with PBS, and ﬁnally stained with DAPI (10236276001, Sigma) or SYTOX Green
nucleic acid stain (S7020, Invitrogen). Both cells and sections were imaged with a
Leica TCS SP5 laser scanning confocal microscope. EU intensity was analyzed in at
least 150 nuclei per line in a semi-automated fashion using constant thresholding
parameters with the Metamorph software(Molecular Devices) or ImageJ software.
Bioinformatics. Microarray data AffymetrixTM mouse 430 V2.0 arrays have been
obtained from 6 Ercc1 Δ/− livers and 6 wildvtype 16 week old mice and have been
used for this study. The data are available through the public repository
ArrayExpress at accession code: E-MEXP-1503. Detailed description about the
samples collection, RNA extraction, cDNA synthesis, microarray hybridization and
scanning is included in a previous report49. Expression intensities were summar-
ized, log2 transformed and normalized using RMA as is implemented in R open
statistical package (http://www.r-project.org/). Linear model from Gentleman
implemented in R 53 was used to calculate the fold change (FC), p value and false
discovery rate (FDR) between Ercc1 Δ/− and wild type samples.
To assess the relationship between gene length and fold-change (FC), probesets
in the AffymetrixTM array with multiple gene annotation were ﬁltered out and
BioMart 54 was used to ask the gene length for the remaining probe sets.
Differentially expressed genes were selected using FDR 540.05 and linear fold
change ± 1.5. Shapiro–Wilk test was applied to contrast the normality of the gene
length distribution in the different list of DEG. The Mann-Whitney for non-paired
samples test was used to evaluate whether the distributions of gene length of DEG
genes were different between up-regulated and down-regulated genes.
In order to increase the understanding of the compromise of several cellular
processes secondary to the accumulation of DNA damage, we evaluated the level
expression of selected genes for core of RNA Pol II and Pentose Phosphate,
Glycolysis/Gluconeogenesis and unfolded protein response (UPR) pathways as are
described in KEGG database. The criteria to identify a gene as differentially
expressed was the same described (FDR < 0.05 and linear fold change ± 1.5).
Intracellular nucleotide pool measurement by HPLC. The measures were per-
formed as previously described74, with minor modiﬁcations. Brieﬂy, liver was
grinded in liquid nitrogen and treated with 0.4 M HClO4. After centrifugation the
supernatant was neutralized with 5M K2CO3. The pellet was used for protein
determination and the supernatant was used to measure and quantiﬁed the
nucleotide pool by HPLC analysis (Alliance 2690; Waters, Milford, MA) using a
Partisphere-SAX anion exchange column (4.6 × 125 mm; Whatman International
Ltd., Maidstone, UK). The following gradient was used: 5 min with 100% buffer A
(5 mM NH4H2PO4, pH 5); a 15-min linear gradient of 100% buffer A to 100%
buffer B (300 mM +NH4H2PO4, pH 5); 20 min with 100% buffer B; a 5-min linear
gradient to 100% buffer A; and equilibration at 100% buffer A for 5 min. The UV
absorbance of the peaks was recorded at 262 nm.
RNA isolation and qPCR. Total RNA was isolated from liver or cells using Trizol
(15596026, Invitrogen), according to the manufacturer’s protocol. First-strand
complementary cDNA was synthesized from 1 µg RNA using SuperScript First-
Strand cDNA Synthesis Kit (11904018, Invitrogen). qPCR was performed on a
C1000 Thermal Cycler, CFX96 Real-Time System (Bio-Rad), SYBR Green I
(4385612, Invitrogen) and Platinum Taq polymerase (10966-083, Invitrogen). The
primer sequences are showed in Supplementary Table 7. Primer efﬁciency and
speciﬁcity have been conﬁrmed. Data were analyzed using the second derivative
maximum method: (E1gene of interestΔCP (cDNA of wt mice - cDNA of Ercc1Δ/- mice) gene of
interest)/(Ehouse keepingΔCP (cDNA wt mice- cDNA of Ercc1Δ/- mice) housekeeping gene). Data
were reported as the average of values obtained from tissues froma minimum of 5
animals ± the standard deviation.
Bioenergetics Assays. Oxygen consumption rates (OCR) and extracellular acid-
iﬁcation rate (ECAR) were measured using a XF-24 Extracellular Flux Analyzer
(Seahorse Bioscience), as previously described75,76. On the experimental day,
medium was changed to unbuffered DMEM (XF Assay Medium–Agilent Tech-
nologies, Santa Clara, Ca, USA) supplemented with 2 mM glutamine, 5 mM glu-
cose and 1 mM sodium pyruvate, and incubated 1 h at 37° C in the absence of CO2.
Medium and reagents acidity was adjusted to pH 7.4 on the day of the assay,
according to manufacturer’s procedure. Hepatocytes were seeded at a density of
3 × 104 cells/well on Cell-Tak (22.4 μg/ml; 354240, BD Biosciences) coated Sea-
horse plates and analyzed 3 h after isolation. Fibroblasts were seeded at a density of
6 × 104 cells/well on uncoated Seahorse plates and analyzed after 24 h. Optimal
cells densities were determined experimentally to ensure a proportional response to
FCCP with cell number (data not shown).
Mitochondrial respiration was measured as oxygen consumption rate (OCR).
After four baseline measurements cells were sequentially challenged with injections
of mitochondrial toxins: 0.5 µM oligomycin (ATP-synthase inhibitor, which
informs on the level of respiration allocated for ATP production), 0.4 μM ﬂuoro-
carbonyl cyanide phenylhydrazone (FCCP, oxidative phosphorylation uncoupler,
which informs on the maximal achievable level of respiration) for hepatocytes or 1
µM for ﬁbroblasts, 1 μM rotenone (complex I inhibitor, which informs on the level
of respiration dependent on complex I) and 1 μM antimycin A (complex III
inhibitor, which completely ablates mitochondrial respiration and informs on the
level of non-mitochondrial respiration). Basal respiration was deﬁned as the
average OCR values at baseline; proton leakage was deﬁned as mitochondrial
respiration detected after oligomycin injection and maximal respiration was
deﬁned as OCR values after FCCP injection. Respiration dedicated to ATP
production was calculated as difference between basal respiration and the
respiration measured after oligomycin injection and the rotenone dependent
respiration parameter–which accounts for mitochondrial complex I activity -was
calculated as the difference between the maximal respiration value and the OCR
values obtained after the rotenone injection.
Glycolysis was measured as extracellular acidiﬁcation rate (ECAR), which
reﬂects lactate production via glucose catabolism. On the experimental day,
medium was changed to unbuffered DMEM (BASE Medium–Agilent
Technologies, Santa Clara, Ca, USA) supplemented with 2 mM glutamine, 1 mM
sodium pyruvate, and incubated 1 h at 37° C in the absence of CO2. Medium and
reagents acidity was adjusted to pH 7.4 on the day of the assay, according to
manufacturer’s procedure. ECAR was measured in basal conditions, after
stimulation with 11 mM glucose, then with 5 μM oligomycin, and ﬁnally inhibited
with 100 mM 2-deoxyglucose (2-DG).
Sugar phosphate quantitative metabolomics. Sugar phosphates were quantiﬁed
by LC–MS/MS, as previously described28. Brieﬂy, metabolites were extracted in
HBSS with 2% perchloric acid, and proteins were precipitated after neutralization
with a phosphate buffer. The samples were subsequently supplemented with an
internal isotope labeled standard 13C6-glucose-6P, separated on a water-acetonitrile
gradient on a C18 RP-HPLC column (LC packings), and analyzed on an API3000
triple quadrupole mass spectrometer (AB/Sciex).
Enzymatic activity assays. PFK (MAK093 Sigma) and G6PD (ab102529,
ABCAM) activity was measured with commercial kits according to the manu-
facturer’s direction.
ATP measurement. ATP (MAK190, Sigma) was measured with commercial kit.
Brieﬂy, tissues were homogenized in ATP assay buffer and the high-molecular
components were removed by size-exclusion ﬁltration using Amicon Ultra-2 10 K
columns (Z740164, Sigma). The colorimetric assay was performed according to
manufacturer’s instructions. ATP/ADP ratio was measured with the ADP/ATP
Ratio Assay Kit (MAK135, Sigma) according to manufacturer’s instructions.
NADP+/NADPH measurement. Tissues were homogenized in lysis buffer (0.1 M
Tris–HCl pH 8.0, 0.01 M EDTA, 0.05% Triton X-100) and mixed with a same
volume of a phenol:chloroform:isoamyl (25:24:1) solution. After centrifugation, the
upper phase was collected and passed onto Phase Lock gel tubes (5Prime) to
remove any organic solvent. The high-molecular components were removed by
size-exclusion ﬁltration using Amicon Ultra 10 K columns (Millipore). Colori-
metric assays were performed using the NADP+/NADPH Quantiﬁcation Kit (JM-
K347-100 MBL) according manufacturer’s instructions.
Glutathione measurement. Total glutathione (GSH) and the ratio between
reduced (GSH) and oxidized (GSSG) glutathione in liver were analyzed by using
Glutathione (GSH/GSSG/Total) Assay kit (K264-100, Biovision). The assay is
based on oxidation of GSH by the sulfhydryl reagent 5,5′-dithio-bis(2-nitrobenzoic
acid) (DTNB) to form 5′-thio-2-nitrobenzoic acid (TNB), which is yellow and thus
spectrophotometrically measurable at 412 nm. Brieﬂy, liver tissues were homo-
genized in ice-cold glutathione assay buffer and mixed with 6 N perchloric acid
(PCA) to precipitate proteins. After centrifugation (13,000 × g for 5 min), the
supernatant was neutralized with half volume of 6 N KOH. Total GSH and GSSG/
GSH levels were determined according manufacturer’s procedure with a GLOMAX
multi detection system spectrophotometer (Promega).
Determination of thiol- disulﬁde redox equilibrium. Assays were performed as
previously described, according to a procedure we refer to as redox immunohis-
tochemistry (RHC)29,30. Brieﬂy, cells or freshly cut tissue sections (10 µm) from
liver were ﬁxed with 4% paraformaldehyde, 1 mM N-ethilmaleymide, 5 µM Alexa
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12640-5 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:4887 | https://doi.org/10.1038/s41467-019-12640-5 | www.nature.com/naturecommunications 13
Fluor 555-Maleimide, 0.05% Triton X-100 for 20 min. Quenching of unreacted
thiols was achieved with 100 mM NEM. The samples were washed twice in PBS
and then incubated for 20 min with 5 mM tris(2-carboxyethyl)phosphine (TCEP)
in PBS. Samples were washed twice in PBS and the second labeling step was
performed by incubating with 5 µM Alexa Fluor 488-Maleimide, 1 mM NEM for
20 min followed by two additional washing steps. Samples were acquired using a
Leica SP5 laser scanning confocal microscope and analyzed using the MetaMorph
software (Molecular Devices). The ratiometric disulﬁde/thiol redox state was cal-
culated as the Alexa488/Alexa555 ratio. Alternatively, oxidized and reduced
cysteines were labeled with IRDye 800 maleimide (Li-COR biosciences) and Alexa
Fluor 680-Maleimide, and proteins were extracted from the samples and resolved
by SDS-electrophoresis; the gel was scanned with an Odyssey Platform (Li-COR
Biosciences) and its Image Studio Lite software was used to analyze the ﬂuorescent
signal of oxidized and reduced cysteines29,30.
Flow cytometry. General ROS was measured with 5-(and 6)-chloromethyl-2′,7′-
dichlorodihydro-ﬂuresceindiacetate, acetyl ester (CM-H2DCFDA, C6827, Mole-
cular Probes), while mitochondrial superoxide production was detected with
MitoSOX Red (M36008, Invitrogen), according to manufacturer’s instructions.
Annexin V/Propidium iodide (PI) staining was also performed according to the
manufacturer’s guidelines. Brieﬂy, cells were treated with diamide dissolved in cell
media at the indicated concentrations. After 4 h, the cells were detached with
trypsin, washed in ice-cold HBSS without Ca2+ and Mg2+ and suspended in 0.1 M
Hepes (pH 7.4) 1.4 M NaCl, 25 mM CaCl2 containing Propidium Iodide (PI;
P4170, Sigma) or Annexin V (550474 BD Biosciences). Cells were incubated for 15
min at room temperature and ﬂow cytometry was immediately performed using
FACSARIA or FACScan (BD Biosciences). FlowJo Software (Tree Star Inc.) was
used for data analysis.
Cell cultures. Isogenic primary mouse embryonic ﬁbroblasts (MEF) lines were
isolated from E13.5 embryos and cultured in low oxygen (3%). Human primary
ﬁbroblasts were cultured at 20% oxygen in DMEM supplemented with 10% fetal
bovine serum (FBS) and 1% Pen/strep. All participants or their legal caretakers
gave written informed consent according to Erasmus MC institutional review
board requirements.
Depending upon the speciﬁc experiment, cells were treated with 50 nM
nucleosides (adenosine, uridine, citydine and guanosine), 10 µg/ml α-amanitin
(Sigma), 5 µg/ml actinomicyn D or 50 µM 5,6-dichloro-1-β-D-
ribofuranosylbenzimidazole (DRB) for the time frame indicated in the
experiments.
Immunoblot procedures. Immunoblot analysis were performed according to the
LI-COR Biosciences Guidelines; images have been acquired by the Odyssey Plat-
form and analyzed by the Image Studio lite software (Li-COR Biosciences). The
following primary antibodies have been used: Thioredoxin-1 (1:5000, AB9328,
Millipore), β-actin (1:5000, MAB1501, Millipore), anti-SLC13A5 (1:1000,
HPA044343, Sigma Aldrich); AMPK-α (1:1000; 2793, Cell Signaling Technologies);
p-AMPK-α (1:1000; 2535, Cell Signaling Technologies); Ubiquitin (1:1000, rabbit
polyclonal Z0458, DAKO and mouse monoclonal FK2, BML-PW8810-0500, Enzo
Life Sciences); total RNA Pol II (RPB1-NTD, 1:1000, 14958 S, Cell Signaling
Technologies); RNA Pol II-phosphoSer5 (1:5000, 3E10, Chromotek); RNA Pol II-
phosphoSer2 (1:5000, 3E8, Chromotek); Tubulin (1:5000, T6074, Sigma). IRDye
secondary antibodies (LI-COR) were used 1:7500.
Brieﬂy, frozen liver samples were extracted in RIPA buffer (150 mM NaCl, 1%
NP40, 0.5% DOC, 0.1% SDS, 50 mM Tris HCl) supplemented with protease and
phosphatase inhibitor from Roche diagnostics. To preserve protein sample
ubiquination, 5 mM EDTA, 5 mM EGTA and 20mM NEM was added to the RIPA
buffer before the extraction. Protein samples were loaded on precast 4–12% Bis-
Tris gradient gel (NuPAGE Novex, NP0335, Invitrogen), separated with NuPAGE
running buffer (NP0002, Invitrogen) and transferred on PVDF membrane
(IPFL00010, Millipore).
To pull down ubiquitinated proteins from liver extracts, Tandem Ubiquitin
Binding Entities (TUBE2) was used coupled to agarose purchased from Boston
BioChem (AM-130). This afﬁnity resin was washed 2 times with RIPA buffer
(150 mM NaCL, 1% NP40, 0.5% DOC, 0.1% SDS, 5 mM EDTA, 5 mM EGTA,
20 mM NEM, 50 mM Tris HCl supplemented with protease and phosphatase
inhibitor from Roche diagnostics). Subsequently, 1 mg protein of each liver extract
(sonicated in RIPA) was incubated with 20 µl of TUBE2-agarose for 3 h on a
Eppendorf rotator at 4 degrees. As a control, a mixture of the tissue lysates was
incubated with 20 µl of Pierce protein G agarose beads (20398, Thermo Scientiﬁc).
Following incubation, beads were washed 4 times with 1 ml of RIPA. To elute and
denature ubiquitinated proteins, 70 μl 2x Laemmli sample buffer was added to the
beads and boiled for 3 min. For detection of ubiquitinated proteins on western blot,
the mouse monoclonal FK2 antibody from Enzo Life Sciences (BML-PW8810-
0500) was used. In addition, RNA pol II (Rpb1) was stained using the phospho-
speciﬁc rat monoclonal antibodies from chromotek (3E8 and 3E10).
Protein carbonylation was measured as previously described77. Carbonyls were
derivatized with 2,4-dinitrophenylhydrazine (DNPH) in 12% SDS, 5%
triﬂuoroacetic acid (TFA), to form 2,4-dinitrophenylhydrazone, which was in turn
detected using an anti-dinitrophenyl primary antibody (1:1000, D8406 Sigma
Aldrich) and a rat anti-mouse IgE-HRP secondary antibody (1:1000, 1130-05,
Southern Biotech). Negative controls were prepared omitting DNPH in the
reaction. Immunoblots were developed with ECL (Amersham Biosciences) and
membranes were acquired using a chemioluminescent imaging system (Uvitec
Cambridge).
In vivo drug treatments. N-acetylcysteine (NAC–A5270, Sigma) and Rotenone
(MP Biomedicals - 150154) have been administered to the mice in a concentration
of 25 g/L and 10 mg/L respectively, dissolved in mice drinking water starting from
the age of 4 weeks. The solutions were freshly prepared and replenished every
3 days. The range of NAC doses was selected on the basis of previous
literature78–80. As far as rotenone is concerned, we took as a starting point the work
of Pan-Montojo and colleagues81; here, a dose of 5 mg/kg principally affected the
gastrointestinal tract, therefore minimizing systemic toxicity. In total 5 mg/kg
correspond to 0.125 mg for an average mouse with 25 grams body weight. Here, we
decided to use a slightly lower dosage than what reported by Pan-Montojo and co-
workers in light of the fragile phenotype of Ercc1 mutants and of their general
sensitivity. We therefore administered 10 mg/mL rotenone in drinking water,
which approximately corresponds to 0.04 mg per mouse per day given that mice
(including Ercc1 mutants) drink ~4 mL of water daily (please see http://web.jhu.
edu/animalcare/procedures/mouse.html).
Metabolic ﬂux analysis. Isogenic primary mouse embryonic ﬁbroblasts (MEF)
derived from WT or ERCC1 D/− were kept in culture to reach conﬂuency (1 ×
106). Cells were then exposed to [1–213C2]Glucose 2 mM (Sigma-Aldrich,
453188) for 6 h. Cells were then washed twice with cold PBS and collected with
scrapers. Tubes were centrifuged at 1000 g for 10′ at 4 °C and then frozen in
liquid nitrogen. Cells were then harvested in 250 µl of ice-cold methanol/acet-
onitrile 1:1 and spun at 20,000 × g for 5 min at 4 °C. Supernatant were then
ﬁltered through a regenerated cellulose ﬁlter, dried and resuspended in 100 µl of
MeOH for subsequent analysis. The analysis was performed on an API-4000
triple quadrupole mass spectrometer (AB Sciex) coupled with a HPLC system
(Agilent) and CTC PAL HTS autosampler (PAL System). The identity of all
metabolites was conﬁrmed using pure standards. Quantiﬁcation of different
metabolites was performed with a liquid chromatography/tandem mass spec-
trometry (LC–MS/MS) method using a cyano-phase LUNA column (50 mm ×
4.6 mm, 5 μm; Phenomenex). Samples were analyzed by a 3 min run in negative
ion mode. The mobile phases were phase A: H20 and phase B: 2 mM ammonium
acetate in MeOH. The gradient was 90% B for all the analysis with a ﬂow rate of
500 µl/min. MultiQuant™ software (version 3.0.2) was used for data analysis and
peak review of chromatograms.
Statistical analysis. Experiments were performed at least in three independent
biological and at least two independent technical replicates. All analysis were
performed using Graph Pad Prism version 7.03 for Windows (GraphPad Software,
La Jolla California USA). P values expressed as *P < 0.05; **P < 0.01, ***P < 0.001
were considered to be signiﬁcant; in absence of indications, comparisons should be
considered non-signiﬁcant. Comparisons for two groups were calculated by
unpaired two-tailed Student’s t tests and comparisons for more than two groups
were calculated by one way ANOVA followed by Dunnet’s multiple comparison
post-hoc test. Survival-curve statistical analysis was performed using the product-
limit method of Kaplan and Meier (Log-rank Mantel-Cox test).
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
A reporting summary for this Article is available as a Supplementary Information ﬁle.
The datasets generated and/or analyzed in Fig. 1c, Supplementary Table 1–5 are available
in the ArrayExpress repository, accession codeE-MEXP-1503, https://www.ebi.ac.uk/
arrayexpress/. Source data for the ﬁgures provided are available as a Source Data ﬁle. All
relevant data supporting the key ﬁndings of this study are available within the article and
its Supplementary Information ﬁles or from the corresponding author upon reasonable
request.
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